Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension

Inclusion Criteria

• •Individual is ≥ 20 and ≤ 80 years old at time of randomization.
• •Individual is receiving a stable medication regimen including full tolerated doses of 3 or more anti-hypertensive medications of different classes, of which one must be a diuretic (with no changes for a minimum of 6 weeks prior to screening) that is expected to be maintained without changes for at least 6 months.
• •Individual has an office systolic blood pressure (SBP) of ≥ 160 mmHg based on an average of 3 blood pressure readings measured at both an initial screening visit and a confirmatory screening visit
• •Individual agrees to have all study procedures performed, and is competent and willing to provide written, informed consent to participate in this clinical study.